Clinical Trials Browser

Phase 2 × Interventional × Keratosis × Clear all

NCT00239135 2015-03-25

Study to Determine the Maximum Tolerated Dose and Safety of PEP005 Topical Gel

Phase 2 Completed

Keratosis, Melanosis, Keratosis, Actinic